Jungang Vaccine Reports 1Q Operating Profit of 1.75 Billion KRW, Up 9.9% YoY

[Asia Economy Reporter Lee Seon-ae] Jungang Vaccine announced on the 27th that its operating profit for the first quarter of this year was tentatively estimated at 1.757 billion KRW, an increase of 9.9% compared to the same period last year. Sales were recorded at 10.353 billion KRW, up 10.8% from the same period last year.

This content was produced with the assistance of AI translation services.